RSM logo
Annals of Clinical Biochemistry

Home Current issue Browse archive Alerts About the journal Feedback
 
This version was published on 1 July 2009
Ann Clin Biochem 2009;46:332-337
doi:10.1258/acb.2009.009023
© 2009 Association for Clinical Biochemistry

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
acb.2009.009023v1
46/4/332    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Coakley, J.
Right arrow Articles by Robins, H.
PubMed
Right arrow PubMed Citation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Original Articles

Sweat testing for cystic fibrosis: standards of performance in Australasia

John Coakley1, Sue Scott2, Richard Mackay3, Ronda Greaves4, Lisa Jolly2, John Massie5, Avantika Mishra6, Anna Bransden7, James C G Doery8, Angela Chiriano4 and Heather Robins9


1 Department of Biochemistry, The Children's Hospital at Westmead, Westmead; 2 RCPA Chemical Pathology Quality Assurance Programs, Adelaide, Australia; 3 Clinical Biochemistry Unit, Canterbury Health Laboratories, Christchurch, New Zealand; 4 Department of Clinical Biochemistry, The Royal Children's Hospital, Melbourne; 5 Department of Respiratory Medicine, The Royal Children's Hospital, Melbourne; 6 Victorian Clinical Genetics Service, Melbourne; 7 Department of Chemical Pathology, Royal Brisbane Hospital, Brisbane; 8 Department of Biochemistry, Monash Medical Centre and Department of Medicine, Monash University, Melbourne; 9 Department of Biochemistry, The Canberra Hospital, ACT, Australia


Corresponding author: Dr John Coakley, Department of Biochemistry, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145, Australia. Email: johnc2{at}chw.edu.au


Background: Accurate measurement of sweat chloride concentration is essential for the diagnosis of cystic fibrosis (CF). We surveyed all laboratories enrolled in the Royal College of Pathologists of Australasia Quality Assurance Program (QAP) for Sweat Electrolytes to determine how closely they comply with the Australian Guidelines for the performance of the sweat test for the diagnosis of CF.

Methods: A detailed questionnaire covering most aspects of sweat collection and analysis was sent to all participating laboratories in 2007.

Results: Twenty out of 38 laboratories completed the questionnaire. While adherence to accepted guidelines was noted in many areas, the following main variations were recorded: some laboratories were not doing enough sweat tests to maintain expertise; some were not collecting sweat for the recommended collection time; sweat conductivity was the only test available in some laboratories; there was a lack of agreement between the sweat chloride concentration used to indicate CF or define an equivocal result.

Conclusions: There is room for improvement in the performance of the sweat test in some laboratories in Australasia. The Sweat Testing Working Party of the Australasian Association of Clinical Biochemists is the appropriate body to address the problems involved in sweat testing and to bring about change.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




How Not to be a Doctor